businesspress24.com - IntelGenx to Report Fourth Quarter and Full Year 2016 Financial Results on March 28, 2017 - Conferen
 

IntelGenx to Report Fourth Quarter and Full Year 2016 Financial Results on March 28, 2017 - Conference Call to Follow

ID: 1493967

(firmenpresse) - SAINT-LAURENT, QUEBEC -- (Marketwired) -- 03/21/17 -- IntelGenx Technologies Corp., (TSX VENTURE: IGX)(OTCQX: IGXT), today announced that it will release its fourth quarter and full year 2016 financial results after market close on March 28, 2017.

An accompanying conference call will be hosted by Dr. Horst G. Zerbe, President and Chief Executive Officer and Mr. Andre Godin, Executive Vice-President and Chief Financial Officer, to discuss the results and provide a business update. Details of the conference call and webcast are below:

Date: Tuesday, March 28, 2017

Time: 4:30 p.m. ET

Conference dial-in: (877) 201-0168

International dial-in: (647) 788-4901

Conference ID: 51039225

Webcast Registration:

Following the live call, a replay will be available on the Company''s website, , under "Investor Relations".

About IntelGenx:

IntelGenx is a leading oral drug delivery company primarily focused on the development and manufacturing of innovative pharmaceutical oral films based on its proprietary VersaFilm™ technology platform. Established in 2003, the Montreal-based company is listed on the TSX-V and OTC-QX.

IntelGenx highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. IntelGenx state-of-the-art manufacturing facility, established for the VersaFilm™ technology platform, supports lab-scale to pilot and commercial-scale production, offering full service capabilities to our clients. More information is available about the company at: .

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange), nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Source: IntelGenx Technologies Corp.





Contacts:
Stephen Kilmer
Investor Relations
(514) 331-7440 ext 232


Andre Godin, CPA, CA
Executive Vice-President and CFO
(514) 331-7440 ext 203

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Nephros Reports 2016 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
Immunotec Provides an Update on Taxation Matters in Mexico
Bereitgestellt von Benutzer: Marketwired
Datum: 21.03.2017 - 15:30 Uhr
Sprache: Deutsch
News-ID 1493967
Anzahl Zeichen: 3497

contact information:
Contact person:
Town:

SAINT-LAURENT, QUEBEC


Phone:

Kategorie:

Health & Nutrition


Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:


Diese Pressemitteilung wurde bisher 507 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"IntelGenx to Report Fourth Quarter and Full Year 2016 Financial Results on March 28, 2017 - Conference Call to Follow
"
steht unter der journalistisch-redaktionellen Verantwortung von

IntelGenx Technologies Corp. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von IntelGenx Technologies Corp.



 

Who is online

All members: 10 561
Register today: 0
Register yesterday: 2
Members online: 0
Guests online: 62


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.